Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Escherichia coli (ATCC 25922) |
- |
- |
0.11 - ? |
Ofloxacin (Floxin) |
665 |
Escherichia coli (ATCC 25922) |
- |
- |
≤0.12 - ? |
Aztreonam-clavulanic acid |
290 |
Escherichia coli (ATCC 25922) |
- |
- |
≤0.12 - ? |
Cefepime (Maxipime) |
290 |
Escherichia coli (ATCC 25922) |
- |
- |
≤0.12 - ? |
Cefepime-clavulanic acid |
290 |
Escherichia coli (ATCC 25922) |
- |
- |
≤0.12 - ? |
Cefotaxime (Cephotaxime, Claforan) |
290 |
Escherichia coli (ATCC 25922) |
- |
- |
≤0.12 - ? |
Cefotaxime-clavulanic acid |
290 |
Escherichia coli (ATCC 25922) |
- |
- |
0.12 - ? |
Fleroxacin (Quinodis) |
401 |
Escherichia coli (ATCC 25922) |
- |
- |
0.12 - ? |
Imipenem |
401 |
Escherichia coli (ATCC 25922) |
- |
- |
0.12 - ? |
Ofloxacin (Floxin) |
1595 |
Escherichia coli (ATCC 25922) |
- |
- |
0.12 - ? |
Tigecycline (GAR-936, Tigacyl) |
34 |
Escherichia coli (ATCC 25922) |
- |
- |
0.12 - ? |
WAY 152288 |
34 |
Escherichia coli (ATCC 25922) |
- |
- |
<0.125 - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
936 |
Escherichia coli (ATCC 25922) |
- |
- |
0.13 - ? |
Triclosan |
186 |
Escherichia coli (ATCC 25922) |
- |
- |
0.18 - 1.46 |
Miconazole/Polymyxin B |
742 |
Escherichia coli (ATCC 25922) |
- |
- |
0.23 - ? |
Aztreonam (Azactam) |
665 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Aztreonam (Azactam) |
401 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Aztreonam (Azactam) |
290 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Bac7(1–35) |
749 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Cefixime (Suprax) |
401 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Cefpodoxime |
401 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
290 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
187 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
187 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
401 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Ceftazidime-Clavulanic acid |
290 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Cholesterol (MC/PA) |
314 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Ibafloxacin |
930 |
Escherichia coli (ATCC 25922) |
- |
- |
0.25 - ? |
Kanamycin (Kantrex) |
242 |